| 2025-06-17 | Wang Lai | Global Head of R&D | Sell | 1,647 | $262.11 | $431,699.06 | -77.8% | → |
| 2025-06-17 | OYLER JOHN | Chief Executive Officer | Sell | 5,140 | $263.33 | $1,353,519.55 | -77.9% | → |
| 2025-06-16 | Wu Xiaobin | President and COO | Sell | 1,543 | $265.52 | $409,694.49 | -53.2% | → |
| 2025-06-16 | Lee Chan Henry | SVP, General Counsel | Sell | 422 | $266.50 | $112,463.00 | -100% | → |
| 2025-06-11 | Ball Titus B. | Principal Accounting Officer | Sell | 134 | $258.36 | $34,620.05 | -100% | → |
| 2025-06-10 | Wang Xiaodong | Director, Chair, Scientific Advisory Brd | Sale+OE | 41,760 | $262.82 | $10,975,315.61 | -37.8% | → |
| 2025-06-06 | OYLER JOHN | Chief Executive Officer | Sell | 5,127 | $252.77 | $1,295,946.05 | -39.7% | → |
| 2025-06-06 | Wu Xiaobin | President and COO | Sell | 1,934 | $253.15 | $489,591.02 | -36.0% | → |
| 2025-06-06 | Wang Lai | Global Head of R&D | Sell | 1,402 | $252.39 | $353,853.30 | -45.2% | → |
| 2025-06-06 | Lee Chan Henry | SVP, General Counsel | Sell | 700 | $256.11 | $179,279.88 | -75.3% | → |
| 2025-05-13 | Wang Xiaodong | Director, Chair, Scientific Advisory Brd | Sale+OE | 41,760 | $223.50 | $9,333,272.13 | -49.8% | → |
| 2025-04-14 | Wang Xiaodong | Director, Chair, Scientific Advisory Brd | Sale+OE | 41,760 | $242.66 | $10,133,595.25 | -16.3% | → |
| 2025-04-01 | Wu Xiaobin | President, COO & GM China | Sale+OE | 51,921 | $281.40 | $14,610,370.12 | -53.0% | → |